
    
      This is a multi-center, long-term safety study to evaluate the safety and tolerability of
      TD-1473 for up to 156 weeks (3 years) + 4 week follow-up in subjects with moderate to severe
      UC exiting the preceding Maintenance Study of Protocol 0157 (NCT03758443).
    
  